ATNXQ — Athenex Income Statement
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
- $0.13m
- $74.91m
- $102.82m
Annual income statement for Athenex, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | R2020 December 31st | R2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 89.1 | 101 | 144 | 95.4 | 103 |
| Cost of Revenue | |||||
| Gross Profit | 42.1 | 31.6 | 49 | 32.5 | 26.7 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 216 | 220 | 274 | 246 | 176 |
| Operating Profit | -127 | -119 | -130 | -150 | -73.1 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -129 | -124 | -140 | -171 | -98.6 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -129 | -125 | -144 | -160 | -99 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -117 | -124 | -146 | -200 | -103 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -117 | -124 | -146 | -200 | -103 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -36.3 | -33.3 | -31.9 | -25.3 | -14.7 |